Publicacions en què col·labora amb RAFAEL SAN JUAN GARRIDO (12)

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

2021

  1. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  2. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  3. Risk factors for the development of invasive aspergillosis after kidney transplantation: Systematic review and meta-analysis

    American Journal of Transplantation, Vol. 21, Núm. 2, pp. 703-716

  4. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

2020

  1. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain

    Transplant Infectious Disease, Vol. 22, Núm. 5

2017

  1. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain

    Transplant Infectious Disease, Vol. 19, Núm. 1

  2. Therapeutisches Verhalten bei asymptomatischer Bakteriurie von Nierentransplantierten

    Nieren- und Hochdruckkrankheiten

2016

  1. Detection of Epstein–Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications

    Transplant Infectious Disease, Vol. 18, Núm. 3, pp. 431-441

  2. Monitoring of intracellular adenosine triphosphate in CD4+ T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients

    Transplant International, Vol. 29, Núm. 10, pp. 1094-1105

  3. Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial

    American Journal of Transplantation, Vol. 16, Núm. 10, pp. 2943-2953